# Glycoprotein Nonmetastatic Melanoma B (Gpnmb)-Positive Macrophages Contribute to the Balance between Fibrosis and Fibrolysis during the Repair of Acute Liver Injury in Mice

**Authors:** Kotaro Kumagai, Kazuaki Tabu, Fumisato Sasaki, Yoichiro Takami, Yuko Morinaga, Seiichi Mawatari, Shinichi Hashimoto, Shiroh Tanoue, Shuji Kanmura, Tsutomu Tamai, Akihiro Moriuchi, Hirofumi Uto, Hirohito Tsubouchi, Akio Ido

PMC · DOI: 10.1371/journal.pone.0143413 · PLoS ONE · 2015-11-23

## TL;DR

This study shows that Gpnmb-positive macrophages help balance liver tissue repair after injury by managing fibrosis and fibrolysis.

## Contribution

The study identifies a novel role for Gpnmb-positive macrophages in liver repair dynamics.

## Key findings

- Gpnmb-positive macrophages are involved in liver recovery by enhancing phagocytic activity and engulfing apoptotic bodies.
- Gpnmb-positive macrophages regulate fibrosis and fibrolysis through increased MMP-13 and collagen production.
- Gpnmb expression in macrophages is stimulated during the recovery phase of liver injury.

## Abstract

Glycoprotein nonmetastatic melanoma B (Gpnmb), a transmembrane glycoprotein that is expressed in macrophages, negatively regulates inflammation. We have reported that Gpnmb is strongly expressed in the livers of rats fed a choline-deficient, L-amino acid-defined (CDAA) diet. However, the role of macrophage-expressed Gpnmb in liver injury is still unknown. This study aimed to clarify the characteristics of infiltrating macrophages that express Gpnmb, and the involvement of Gpnmb in the repair process in response to liver injury.

C57BL/6J, DBA/2J [DBA] and DBA/2J-Gpnmb+ [DBA-g+] mice were treated with a single intraperitoneal injection of carbon tetrachloride (CCl4) at a dose of 1.0 mL/kg body weight. Mice were sacrificed at predetermined time points, followed by measurement of serum alanine aminotransferase (ALT) levels and histological examination. Expression of Gpnmb, pro-/anti-inflammatory cytokines, and profibrotic/antifibrotic factors were examined by quantitative RT-PCR and/or Western blotting. Immunohistochemistry, fluorescent immunostaining and flow cytometry were used to determine the expression of Gpnmb, CD68, CD11b and α-SMA, phagocytic activity, and the presence of apoptotic bodies. We used quantitative RT-PCR and ELISA to examine TGF-β and MMP-13 expression and the concentrations and supernatants of isolated infiltrating hepatic macrophages transfected with siGpnmb.

In C57BL/6J mice, serum ALT levels increased at two days after CCl4 injection and decreased at four days. Gpnmb expression in the liver was stimulated four days after CCl4 injection. Histological examination and flow cytometry showed that Gpnmb-positive cells were almost positive for CD68-positive macrophages, contained engulfed apoptotic bodies and exhibited enhanced phagocytic activity. Isolated infiltrating hepatic macrophages transfected with siGpnmb showed high MMP-13 secretion. There was no significant difference in the magnitude of CCl4-induced liver injury between DBA-g+ and DBA mice. However, hepatic MMP-13 expression, as well as α-SMA expression and collagen production, increased significantly in DBA-g+ compared with DBA mice.

Gpnmb-positive macrophages infiltrate the liver during the recovery phase of CCl4–induced acute liver injury and contribute to the balance between fibrosis and fibrolysis in the repair process following acute liver injury.

## Linked entities

- **Genes:** GPNMB (glycoprotein nmb) [NCBI Gene 10457], TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040], MMP13 (matrix metallopeptidase 13) [NCBI Gene 4322], CD68 (CD68 molecule) [NCBI Gene 968], ITGAM (integrin subunit alpha M) [NCBI Gene 3684], ACTA1 (actin alpha 1, skeletal muscle) [NCBI Gene 58]
- **Chemicals:** carbon tetrachloride (PubChem CID 5943), CCl4 (PubChem CID 5943), alanine aminotransferase (PubChem CID 251717), ALT (PubChem CID 10219674)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Sdc4 (syndecan 4) [NCBI Gene 20971] {aka S4, Synd4, ryudocan, syndecan-4}, Ccl2 (C-C motif chemokine ligand 2) [NCBI Gene 20296] {aka HC11, JE, MCAF, MCP-1, MCP1, SMC-CF}, CD68 (CD68 molecule) [NCBI Gene 968] {aka GP110, LAMP4, SCARD1}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Itgam (integrin alpha M) [NCBI Gene 16409] {aka CD11b/CD18, CR3, CR3A, Cd11b, F730045J24Rik, Ly-40}, Dnase1 (deoxyribonuclease I) [NCBI Gene 13419] {aka DNaseI, Dnl1}, Fcr (Fc receptor) [NCBI Gene 109615], Timp1 (tissue inhibitor of metalloproteinase 1) [NCBI Gene 21857] {aka Clgi, EPA, TIMP-1, TPA-S1, Timp}, Gpt (glutamic pyruvic transaminase, soluble) [NCBI Gene 76282] {aka 1300007J06Rik, 2310022B03Rik, ALT, ALT1, Gpt-1, Gpt1}, Mmp13 (matrix metallopeptidase 13) [NCBI Gene 17386] {aka Clg, MMP-13, Mmp1}, Cd68 (CD68 antigen) [NCBI Gene 12514] {aka Lamp4, Scard1, gp110}, Acta2 (actin alpha 2, smooth muscle, aorta) [NCBI Gene 11475] {aka 0610041G09Rik, Actvs, SMAalpha, SMalphaA, a-SMA, alphaSMA}, Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, TIMP1 (TIMP metallopeptidase inhibitor 1) [NCBI Gene 7076] {aka CLGI, EPA, EPO, HCI, TIMP, TIMP-1}, Ccl4 (C-C motif chemokine ligand 4) [NCBI Gene 20303] {aka AT744.1, Act-2, MIP-1B, Mip1b, Scya4}, Col1a1 (collagen, type I, alpha 1) [NCBI Gene 12842] {aka Col1a-1, Cola-1, Cola1, Mov-13, Mov13}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Gpnmb (glycoprotein nmb) [NCBI Gene 113955], Apc (APC, WNT signaling pathway regulator) [NCBI Gene 11789] {aka CC1, Min, mAPC}, GPNMB (glycoprotein nmb) [NCBI Gene 10457] {aka HGFIN, NMB, PLCA3}, Mmp9 (matrix metallopeptidase 9) [NCBI Gene 17395] {aka B/MMP9, Clg4b, Gel B, MMP-9, pro-MMP-9}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Nos2 (nitric oxide synthase 2, inducible) [NCBI Gene 18126] {aka MAC-NOS, NOS-II, Nos-2, Nos2a, i-NOS, iNOS}, Mmp3 (matrix metallopeptidase 3) [NCBI Gene 17392] {aka EMS-2, MMP-3, SL-1, SLN-1, SLN1, STR-1}, ITGAM (integrin subunit alpha M) [NCBI Gene 3684] {aka CD11B, CR3A, HNA-4, MAC-1, MAC1A, MO1A}, Gpnmb (glycoprotein (transmembrane) nmb) [NCBI Gene 93695] {aka DC-HIL, Dchil, ipd}, Retnla (resistin like alpha) [NCBI Gene 57262] {aka 1810019L16Rik, Fizz-1, Fizz1, HIMF, RELM-alpha, RELMa}, Arg1 (arginase, liver) [NCBI Gene 11846] {aka AI, Arg-1, PGIF}, Chil3 (chitinase-like 3) [NCBI Gene 12655] {aka Chi3l3, ECF-L, Ym1}, Fas (Fas cell surface death receptor) [NCBI Gene 14102] {aka APO1, APT1, CD95, TNFR6, Tnfrsf6, lpr}, DNTT (DNA nucleotidylexotransferase) [NCBI Gene 1791] {aka TDT}, MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313] {aka CLG4, CLG4A, MMP-2, MMP-II, MONA, TBE-1}, Mrc1 (mannose receptor, C type 1) [NCBI Gene 17533] {aka CD206, MR}, MMP13 (matrix metallopeptidase 13) [NCBI Gene 4322] {aka CLG3, MANDP1, MDST, MMP-13}, MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318] {aka CLG4B, GELB, MANDP2, MMP-9}
- **Diseases:** injured liver tissues (MESH:D008107), Acute Liver Injury (MESH:D017114), Fibrosis (MESH:D005355), Centrilobular necrosis (MESH:D011656), necrotic (MESH:D009336), Hepatic (MESH:D056486), cervical dislocation (MESH:D002575), breast cancer metastasis (MESH:D001943), hepatic fibrosis (MESH:D008103), weight loss (MESH:D015431), inflammation (MESH:D007249), inflammatory cell (MESH:D002292), chronic liver injury (MESH:D056487), cholestatic livers (MESH:D017093), ischemia reperfusion injury (MESH:D015427), bone (MESH:D001847), inflammatory cytokines (MESH:D000080424), injury (MESH:D014947), hepatoma (MESH:D006528), necrotic debris (MESH:C536356), melanoma (MESH:D008545), OA (MESH:D010003),  (MESH:D000208)
- **Chemicals:** Pen (MESH:C058388), dimethylnitrosamine (MESH:D004128), paraformaldehyde (MESH:C003043), polyvinylidene fluoride (MESH:C024865), SDS (MESH:D012967), clodronate (MESH:D004002), deoxyuridine triphosphate (MESH:C027078), FITC (MESH:D016650), lipopolysaccharide (MESH:D008070), DAPI (MESH:C007293), L-amino acid (MESH:D000596), paraffin (MESH:D010232), CCl4 (MESH:D002251), Trizol (MESH:C411644), GC Duplexes (-), Percoll (MESH:C016039), formalin (MESH:D005557), PBS (MESH:D007854), sodium pentobarbital (MESH:D010424), thioglycolate (MESH:D013864), Hematoxylin (MESH:D006416), trypan blue (MESH:D014343), heparin (MESH:D006493), choline (MESH:D002794),  (MESH:D016212),  (MESH:C067980),  (MESH:D015214),  (MESH:D015703)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** 5X105 — Mus musculus (Mouse), Hybridoma (CVCL_B0LM), LMNCs — Rattus norvegicus (Rat), Spontaneously immortalized cell line (CVCL_WI63), DBA/2J — Mus musculus (Mouse), Finite cell line (CVCL_6496), C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC4657955/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC4657955/full.md

## References

44 references — full list in the complete paper: https://tomesphere.com/paper/PMC4657955/full.md

---
Source: https://tomesphere.com/paper/PMC4657955